Annual CFF
$5.00 M
+$553.00 M+100.91%
31 December 2023
Summary:
Boston Scientific annual cash flow from financing activities is currently $5.00 million, with the most recent change of +$553.00 million (+100.91%) on 31 December 2023. During the last 3 years, it has fallen by -$288.00 million (-98.29%). BSX annual CFF is now -99.94% below its all-time high of $8.44 billion, reached on 31 December 2006.BSX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$7.00 M
-$17.00 M-70.83%
30 September 2024
Summary:
Boston Scientific quarterly cash flow from financing activities is currently $7.00 million, with the most recent change of -$17.00 million (-70.83%) on 30 September 2024. Over the past year, it has dropped by -$9.00 million (-56.25%). BSX quarterly CFF is now -99.91% below its all-time high of $7.72 billion, reached on 30 June 2006.BSX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$1.61 B
-$9.00 M-0.55%
30 September 2024
Summary:
Boston Scientific TTM cash flow from financing activities is currently $1.61 billion, with the most recent change of -$9.00 million (-0.55%) on 30 September 2024. Over the past year, it has increased by +$1.62 billion (+18044.44%). BSX TTM CFF is now -80.86% below its all-time high of $8.44 billion, reached on 31 December 2006.BSX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BSX Cash From Financing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +100.9% | -56.3% | +10000.0% |
3 y3 years | -98.3% | +16.7% | +278.3% |
5 y5 years | -99.7% | -99.5% | -60.8% |
BSX Cash From Financing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -98.3% | +100.9% | -99.5% | +102.0% | -1.7% | +278.3% |
5 y | 5 years | -99.8% | +100.9% | -99.5% | +100.8% | -60.8% | +239.1% |
alltime | all time | -99.9% | +100.3% | -99.9% | +100.7% | -80.9% | +179.6% |
Boston Scientific Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $7.00 M(-70.8%) | $1.61 B(-0.6%) |
June 2024 | - | $24.00 M(-98.5%) | $1.62 B(-1.2%) |
Mar 2024 | - | $1.57 B(>+9900.0%) | $1.64 B(>+9900.0%) |
Dec 2023 | $5.00 M(-100.9%) | $15.00 M(-6.3%) | $5.00 M(-155.6%) |
Sept 2023 | - | $16.00 M(-62.8%) | -$9.00 M(-96.0%) |
June 2023 | - | $43.00 M(-162.3%) | -$224.00 M(-63.3%) |
Mar 2023 | - | -$69.00 M(-7000.0%) | -$611.00 M(+11.5%) |
Dec 2022 | -$548.00 M(+476.8%) | $1.00 M(-100.5%) | -$548.00 M(-1.6%) |
Sept 2022 | - | -$199.00 M(-42.2%) | -$557.00 M(+58.2%) |
June 2022 | - | -$344.00 M(+5633.3%) | -$352.00 M(+5766.7%) |
Mar 2022 | - | -$6.00 M(-25.0%) | -$6.00 M(-93.7%) |
Dec 2021 | -$95.00 M(-132.4%) | -$8.00 M(-233.3%) | -$95.00 M(-89.5%) |
Sept 2021 | - | $6.00 M(+200.0%) | -$906.00 M(-22.0%) |
June 2021 | - | $2.00 M(-102.1%) | -$1.16 B(+1901.7%) |
Mar 2021 | - | -$95.00 M(-88.4%) | -$58.00 M(-119.8%) |
Dec 2020 | $293.00 M(-90.1%) | -$819.00 M(+228.9%) | $293.00 M(-24.5%) |
Sept 2020 | - | -$249.00 M(-122.5%) | $388.00 M(-80.1%) |
June 2020 | - | $1.10 B(+331.6%) | $1.95 B(+77.0%) |
Mar 2020 | - | $256.00 M(-135.4%) | $1.10 B(-62.9%) |
Dec 2019 | $2.97 B(+107.6%) | -$724.00 M(-155.1%) | $2.97 B(-27.9%) |
Sept 2019 | - | $1.31 B(+413.3%) | $4.12 B(+39.3%) |
June 2019 | - | $256.00 M(-88.0%) | $2.96 B(-13.7%) |
Mar 2019 | - | $2.13 B(+400.5%) | $3.43 B(+139.5%) |
Dec 2018 | $1.43 B(+1201.8%) | $425.00 M(+181.5%) | $1.43 B(+52.5%) |
Sept 2018 | - | $151.00 M(-79.2%) | $939.00 M(+44.7%) |
June 2018 | - | $726.00 M(+458.5%) | $649.00 M(+154.5%) |
Mar 2018 | - | $130.00 M(-291.2%) | $255.00 M(+131.8%) |
Dec 2017 | $110.00 M(-153.4%) | -$68.00 M(-51.1%) | $110.00 M(-46.6%) |
Sept 2017 | - | -$139.00 M(-141.9%) | $206.00 M(-45.6%) |
June 2017 | - | $332.00 M(-2313.3%) | $379.00 M(-322.9%) |
Mar 2017 | - | -$15.00 M(-153.6%) | -$170.00 M(-17.5%) |
Dec 2016 | -$206.00 M(-116.1%) | $28.00 M(-17.6%) | -$206.00 M(-56.3%) |
Sept 2016 | - | $34.00 M(-115.7%) | -$471.00 M(-284.0%) |
June 2016 | - | -$217.00 M(+325.5%) | $256.00 M(-80.6%) |
Mar 2016 | - | -$51.00 M(-78.5%) | $1.32 B(+3.4%) |
Dec 2015 | $1.28 B(-950.7%) | -$237.00 M(-131.1%) | $1.28 B(-14.9%) |
Sept 2015 | - | $761.00 M(-10.0%) | $1.50 B(+98.3%) |
June 2015 | - | $846.00 M(-1000.0%) | $756.00 M(-1000.0%) |
Mar 2015 | - | -$94.00 M(+571.4%) | -$84.00 M(-44.0%) |
Dec 2014 | -$150.00 M(-76.0%) | -$14.00 M(-177.8%) | -$150.00 M(-62.6%) |
Sept 2014 | - | $18.00 M(+200.0%) | -$401.00 M(-28.0%) |
June 2014 | - | $6.00 M(-103.8%) | -$557.00 M(-16.9%) |
Mar 2014 | - | -$160.00 M(-39.6%) | -$670.00 M(+7.4%) |
Dec 2013 | -$624.00 M(-18.3%) | -$265.00 M(+92.0%) | -$624.00 M(+0.5%) |
Sept 2013 | - | -$138.00 M(+29.0%) | -$621.00 M(-14.0%) |
June 2013 | - | -$107.00 M(-6.1%) | -$722.00 M(-3.2%) |
Mar 2013 | - | -$114.00 M(-56.5%) | -$746.00 M(-2.4%) |
Dec 2012 | -$764.00 M(-55.8%) | -$262.00 M(+9.6%) | -$764.00 M(-5.7%) |
Sept 2012 | - | -$239.00 M(+82.4%) | -$810.00 M(+8.0%) |
June 2012 | - | -$131.00 M(-0.8%) | -$750.00 M(-45.2%) |
Mar 2012 | - | -$132.00 M(-57.1%) | -$1.37 B(-20.8%) |
Dec 2011 | -$1.73 B(+240.2%) | -$308.00 M(+72.1%) | -$1.73 B(-14.8%) |
Sept 2011 | - | -$179.00 M(-76.1%) | -$2.03 B(+10.5%) |
June 2011 | - | -$750.00 M(+52.7%) | -$1.84 B(+81.2%) |
Mar 2011 | - | -$491.00 M(-19.4%) | -$1.01 B(+99.4%) |
Dec 2010 | -$508.00 M(-38.0%) | -$609.00 M(-4450.0%) | -$508.00 M(+1853.8%) |
Sept 2010 | - | $14.00 M(-80.8%) | -$26.00 M(-89.4%) |
June 2010 | - | $73.00 M(+421.4%) | -$246.00 M(-22.6%) |
Mar 2010 | - | $14.00 M(-111.0%) | -$318.00 M(-61.2%) |
Dec 2009 | -$820.00 M(-39.3%) | -$127.00 M(-38.3%) | -$820.00 M(+18.8%) |
Sept 2009 | - | -$206.00 M(<-9900.0%) | -$690.00 M(-29.4%) |
June 2009 | - | $1.00 M(-100.2%) | -$977.00 M(-21.1%) |
Mar 2009 | - | -$488.00 M(<-9900.0%) | -$1.24 B(-8.2%) |
Dec 2008 | -$1.35 B | $3.00 M(-100.6%) | -$1.35 B(-4.2%) |
Sept 2008 | - | -$493.00 M(+88.9%) | -$1.41 B(-13.8%) |
June 2008 | - | -$261.00 M(-56.4%) | -$1.63 B(+24.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2008 | - | -$599.00 M(+969.6%) | -$1.31 B(+92.6%) |
Dec 2007 | -$680.00 M(-108.1%) | -$56.00 M(-92.2%) | -$680.00 M(+11.5%) |
Sept 2007 | - | -$718.00 M(-1239.7%) | -$610.00 M(-558.6%) |
June 2007 | - | $63.00 M(+103.2%) | $133.00 M(-98.3%) |
Mar 2007 | - | $31.00 M(+121.4%) | $7.79 B(-7.7%) |
Dec 2006 | $8.44 B(-984.6%) | $14.00 M(-44.0%) | $8.44 B(+6.2%) |
Sept 2006 | - | $25.00 M(-99.7%) | $7.95 B(-5.1%) |
June 2006 | - | $7.72 B(+1040.8%) | $8.37 B(+1082.6%) |
Mar 2006 | - | $677.00 M(-242.2%) | $708.00 M(-174.2%) |
Dec 2005 | -$954.00 M(-317.3%) | -$476.00 M(-206.0%) | -$954.00 M(-5.2%) |
Sept 2005 | - | $449.00 M(+674.1%) | -$1.01 B(-32.3%) |
June 2005 | - | $58.00 M(-105.9%) | -$1.49 B(+149.6%) |
Mar 2005 | - | -$985.00 M(+86.6%) | -$595.00 M(-235.5%) |
Dec 2004 | $439.00 M(-9.9%) | -$528.00 M(+1660.0%) | $439.00 M(-61.3%) |
Sept 2004 | - | -$30.00 M(-103.2%) | $1.13 B(-6.4%) |
June 2004 | - | $948.00 M(+1834.7%) | $1.21 B(+255.1%) |
Mar 2004 | - | $49.00 M(-70.5%) | $341.00 M(-30.0%) |
Dec 2003 | $487.00 M(-378.3%) | $166.00 M(+245.8%) | $487.00 M(+109.9%) |
Sept 2003 | - | $48.00 M(-38.5%) | $232.00 M(+95.0%) |
June 2003 | - | $78.00 M(-60.0%) | $119.00 M(-440.0%) |
Mar 2003 | - | $195.00 M(-319.1%) | -$35.00 M(-80.0%) |
Dec 2002 | -$175.00 M(-140.0%) | -$89.00 M(+36.9%) | -$175.00 M(+230.2%) |
Sept 2002 | - | -$65.00 M(-14.5%) | -$53.00 M(-152.5%) |
June 2002 | - | -$76.00 M(-238.2%) | $101.00 M(-75.0%) |
Mar 2002 | - | $55.00 M(+66.7%) | $404.00 M(-7.6%) |
Dec 2001 | $437.00 M(-168.5%) | $33.00 M(-62.9%) | $437.00 M(+55.0%) |
Sept 2001 | - | $89.00 M(-60.8%) | $282.00 M(+1384.2%) |
June 2001 | - | $227.00 M(+158.0%) | $19.00 M(-104.6%) |
Mar 2001 | - | $88.00 M(-172.1%) | -$409.00 M(-35.9%) |
Dec 2000 | -$638.00 M(+7.6%) | -$122.00 M(-29.9%) | -$638.00 M(-6.9%) |
Sept 2000 | - | -$174.00 M(-13.4%) | -$685.00 M(-12.6%) |
June 2000 | - | -$201.00 M(+42.6%) | -$784.00 M(+17.9%) |
Mar 2000 | - | -$141.00 M(-16.6%) | -$665.00 M(+12.1%) |
Dec 1999 | -$593.00 M(-130.5%) | -$169.00 M(-38.1%) | -$593.00 M(-15.3%) |
Sept 1999 | - | -$273.00 M(+232.9%) | -$700.00 M(-142.3%) |
June 1999 | - | -$82.00 M(+18.8%) | $1.66 B(-6.8%) |
Mar 1999 | - | -$69.00 M(-75.0%) | $1.78 B(-8.5%) |
Dec 1998 | $1.94 B(+1099.4%) | -$276.00 M(-113.3%) | $1.94 B(-14.6%) |
Sept 1998 | - | $2.08 B(+5241.0%) | $2.28 B(+818.2%) |
June 1998 | - | $39.00 M(-59.8%) | $247.80 M(-5.5%) |
Mar 1998 | - | $97.00 M(+72.3%) | $262.10 M(+61.8%) |
Dec 1997 | $162.00 M(-18.7%) | $56.30 M(+1.4%) | $162.00 M(+17.1%) |
Sept 1997 | - | $55.50 M(+4.1%) | $138.40 M(+115.6%) |
June 1997 | - | $53.30 M(-1819.4%) | $64.20 M(-62.7%) |
Mar 1997 | - | -$3.10 M(-109.5%) | $172.30 M(-13.5%) |
Dec 1996 | $199.30 M(+1913.1%) | $32.70 M(-274.9%) | $199.30 M(+4.9%) |
Sept 1996 | - | -$18.70 M(-111.6%) | $190.00 M(-1.6%) |
June 1996 | - | $161.40 M(+575.3%) | $193.00 M(+430.2%) |
Mar 1996 | - | $23.90 M(+2.1%) | $36.40 M(+267.7%) |
Dec 1995 | $9.90 M(+98.0%) | $23.40 M(-249.0%) | $9.90 M(-193.4%) |
Sept 1995 | - | -$15.70 M(-427.1%) | -$10.60 M(-207.1%) |
June 1995 | - | $4.80 M(-284.6%) | $9.90 M(+67.8%) |
Mar 1995 | - | -$2.60 M(-189.7%) | $5.90 M(+18.0%) |
Dec 1994 | $5.00 M(-109.8%) | $2.90 M(-39.6%) | $5.00 M(-256.3%) |
Sept 1994 | - | $4.80 M(+500.0%) | -$3.20 M(-87.7%) |
June 1994 | - | $800.00 K(-122.9%) | -$26.10 M(-51.9%) |
Mar 1994 | - | -$3.50 M(-34.0%) | -$54.30 M(+6.5%) |
Dec 1993 | -$51.00 M(-152.1%) | -$5.30 M(-70.7%) | -$51.00 M(+11.1%) |
Sept 1993 | - | -$18.10 M(-33.9%) | -$45.90 M(+63.9%) |
June 1993 | - | -$27.40 M(>+9900.0%) | -$28.00 M(-126.4%) |
Mar 1993 | - | -$200.00 K(0.0%) | $106.10 M(+8.4%) |
Dec 1992 | $97.90 M(-841.7%) | -$200.00 K(0.0%) | $97.90 M(-0.2%) |
Sept 1992 | - | -$200.00 K(-100.2%) | $98.10 M(-0.2%) |
June 1992 | - | $106.70 M(-1370.2%) | $98.30 M(-1270.2%) |
Mar 1992 | - | -$8.40 M | -$8.40 M |
Dec 1991 | -$13.20 M | - | - |
FAQ
- What is Boston Scientific annual cash flow from financing activities?
- What is the all time high annual CFF for Boston Scientific?
- What is Boston Scientific annual CFF year-on-year change?
- What is Boston Scientific quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Boston Scientific?
- What is Boston Scientific quarterly CFF year-on-year change?
- What is Boston Scientific TTM cash flow from financing activities?
- What is the all time high TTM CFF for Boston Scientific?
- What is Boston Scientific TTM CFF year-on-year change?
What is Boston Scientific annual cash flow from financing activities?
The current annual CFF of BSX is $5.00 M
What is the all time high annual CFF for Boston Scientific?
Boston Scientific all-time high annual cash flow from financing activities is $8.44 B
What is Boston Scientific annual CFF year-on-year change?
Over the past year, BSX annual cash flow from financing activities has changed by +$553.00 M (+100.91%)
What is Boston Scientific quarterly cash flow from financing activities?
The current quarterly CFF of BSX is $7.00 M
What is the all time high quarterly CFF for Boston Scientific?
Boston Scientific all-time high quarterly cash flow from financing activities is $7.72 B
What is Boston Scientific quarterly CFF year-on-year change?
Over the past year, BSX quarterly cash flow from financing activities has changed by -$9.00 M (-56.25%)
What is Boston Scientific TTM cash flow from financing activities?
The current TTM CFF of BSX is $1.61 B
What is the all time high TTM CFF for Boston Scientific?
Boston Scientific all-time high TTM cash flow from financing activities is $8.44 B
What is Boston Scientific TTM CFF year-on-year change?
Over the past year, BSX TTM cash flow from financing activities has changed by +$1.62 B (+18044.44%)